These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 9638316)
21. Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. Todorova A; Vonderheid-Guth B; Dimpfel W J Clin Pharmacol; 2001 Jun; 41(6):636-44. PubMed ID: 11402632 [TBL] [Abstract][Full Text] [Related]
22. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder. Goldenberg MM Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730 [TBL] [Abstract][Full Text] [Related]
23. Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women. Goode PS; Burgio KL; Locher JL; Umlauf MG; Lloyd LK; Roth DL J Am Geriatr Soc; 2002 May; 50(5):808-16. PubMed ID: 12028165 [TBL] [Abstract][Full Text] [Related]
24. Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia. Madersbacher H; Stöhrer M; Richter R; Burgdörfer H; Hachen HJ; Mürtz G Br J Urol; 1995 Apr; 75(4):452-6. PubMed ID: 7788255 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of various spasmolytic drugs on isolated human and porcine detrusor smooth muscle. Uckert S; Stief CG; Odenthal KP; Becker AJ; Truss MC; Jonas U Arzneimittelforschung; 1998 Aug; 48(8):836-9. PubMed ID: 9748713 [TBL] [Abstract][Full Text] [Related]
31. In vitro intravesical instillation of anticholinergic, antispasmodic and calcium blocking agents (rabbit whole bladder model). Kato K; Kitada S; Chun A; Wein AJ; Levin RM J Urol; 1989 Jun; 141(6):1471-5. PubMed ID: 2566693 [TBL] [Abstract][Full Text] [Related]
32. Trospium chloride for the treatment of detrusor instability in children. Lopez Pereira P; Miguelez C; Caffarati J; Estornell F; Anguera A J Urol; 2003 Nov; 170(5):1978-81. PubMed ID: 14532838 [TBL] [Abstract][Full Text] [Related]
33. Time to onset of improvement in symptoms of overactive bladder using antimuscarinic treatment. Rudy D; Cline K; Harris R; Goldberg K; Dmochowski R BJU Int; 2006 Mar; 97(3):540-6. PubMed ID: 16469022 [TBL] [Abstract][Full Text] [Related]
34. Effect of intravesical instillation of varying doses of verapamil (20 mg, 40 mg, 80 mg) upon urinary bladder function in chronic traumatic paraplegics with overactive detrusor function. Babu R; Vaidyanathan S; Sankaranarayan A; Indudhara R Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):350-4. PubMed ID: 2272717 [TBL] [Abstract][Full Text] [Related]
35. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Yarker YE; Goa KL; Fitton A Drugs Aging; 1995 Mar; 6(3):243-62. PubMed ID: 7620236 [TBL] [Abstract][Full Text] [Related]
36. Histopathologic and Urodynamic Effects of the Anticholinergic Drugs Oxybutynin, Tolterodine, and Trospium on the Bladder. Orgen S; Deliktas H; Sahin H; Gedik A; Nergis Y Low Urin Tract Symptoms; 2017 Jan; 9(1):52-56. PubMed ID: 28120444 [TBL] [Abstract][Full Text] [Related]
37. Trospium chloride in patients with neurogenic detrusor overactivity: is dose titration of benefit to the patients? Menarini M; Del Popolo G; Di Benedetto P; Haselmann J; Bödeker RH; Schwantes U; Madersbacher H; Int J Clin Pharmacol Ther; 2006 Dec; 44(12):623-32. PubMed ID: 17190372 [TBL] [Abstract][Full Text] [Related]
38. Intravesical instillation of drugs in patients with detrusor hyperactivity. Ekström B Scand J Urol Nephrol Suppl; 1992; 149():1-67. PubMed ID: 1290084 [TBL] [Abstract][Full Text] [Related]